Back
ESC Premium Access

Opportunities and limitations of iPSC technology in cardiovascular disease

Session: Cardiac regeneration and disease modelling with induced Pluripotent Stem Cells (iPSC)
Topic: Stem cells and cell therapy
Speaker: Doctor R. Zweigerdt (Hannover, DE)
Event: ESC Congress 2017

Congress Presentation

Add to my library

Like

About the speaker

Doctor Robert Zweigerdt

Hannover Medical School, Hannover (Germany)
1 presentation
0 follower

4 more presentations in this session

State of the Art: disease modelling with iPSC.

Speaker: Professor P. Van Der Meer (Groningen, NL)

Access
Slides
Video
Like
Thumbnail

Human embryonic stem cell derived epicardial cells advance cardiomyocyte-based heart regeneration

Speaker: Doctor J. Bargehr (University of Cambridge, GB)

Access
Abstract
Like
Thumbnail

Human iPS cell-derived cardiac tissue (HiCT) for cardiac regenerative therapy

Speaker: Doctor H. Masumoto (Kobe, JP)

Access
Abstract
Slides
Video
Like
Thumbnail

Initiation of the first heart beat and its role in cardiomyocyte differentiation

Speaker: Doctor R. Tyser (Oxford, GB)

Access
Abstract
Like
Thumbnail

Access the full session

Cardiac regeneration and disease modelling with induced Pluripotent Stem Cells (iPSC)

Speakers: Doctor R. Zweigerdt, Professor P. Van Der Meer, Doctor J. Bargehr, Doctor H. Masumoto, Doctor R. Tyser
Access
Like
Thumbnail

About the event

Image

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources